Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=35422332-4b50-4b18-8c73-c731e9b5af56
Date 10/22/2013
Company Name Lycera
Mailing Address 2800 Plymouth Rd Ann Arbor, MI 48109
Company Description Lycera is an early-stage pharmaceutical company developing first-in-class drugs to treat immune disorders. Lycera’s technology platforms include proprietary small molecules that modulate a target, which is central to cellular bioenergetics along with molecules that target the Th17 pathway.
Proceeds Purposes proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for any additional information, including solicitation if applicable.